nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2C19—Rosuvastatin—atherosclerosis	0.068	0.113	CbGbCtD
Doxazosin—CYP2C19—Simvastatin—atherosclerosis	0.0632	0.105	CbGbCtD
Doxazosin—CYP2C19—Lovastatin—atherosclerosis	0.0618	0.103	CbGbCtD
Doxazosin—CYP2D6—Niacin—atherosclerosis	0.0608	0.101	CbGbCtD
Doxazosin—ABCB1—Ezetimibe—atherosclerosis	0.0549	0.0912	CbGbCtD
Doxazosin—ABCB1—Simvastatin—atherosclerosis	0.051	0.0848	CbGbCtD
Doxazosin—ABCB1—Lovastatin—atherosclerosis	0.0499	0.083	CbGbCtD
Doxazosin—ABCB1—Pravastatin—atherosclerosis	0.0499	0.083	CbGbCtD
Doxazosin—CYP2D6—Simvastatin—atherosclerosis	0.048	0.0799	CbGbCtD
Doxazosin—CYP2D6—Pravastatin—atherosclerosis	0.047	0.0782	CbGbCtD
Doxazosin—CYP2D6—Lovastatin—atherosclerosis	0.047	0.0782	CbGbCtD
Doxazosin—Visual impairment—Niacin—atherosclerosis	0.000583	0.00184	CcSEcCtD
Doxazosin—Alopecia—Simvastatin—atherosclerosis	0.000582	0.00184	CcSEcCtD
Doxazosin—Back pain—Ezetimibe—atherosclerosis	0.000582	0.00184	CcSEcCtD
Doxazosin—Muscle spasms—Ezetimibe—atherosclerosis	0.000579	0.00183	CcSEcCtD
Doxazosin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000578	0.00183	CcSEcCtD
Doxazosin—Vision blurred—Lovastatin—atherosclerosis	0.000578	0.00183	CcSEcCtD
Doxazosin—Mental disorder—Simvastatin—atherosclerosis	0.000578	0.00183	CcSEcCtD
Doxazosin—Tremor—Lovastatin—atherosclerosis	0.000575	0.00182	CcSEcCtD
Doxazosin—Visual impairment—Pravastatin—atherosclerosis	0.000574	0.00182	CcSEcCtD
Doxazosin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000569	0.0018	CcSEcCtD
Doxazosin—Eye disorder—Niacin—atherosclerosis	0.000566	0.00179	CcSEcCtD
Doxazosin—Flatulence—Simvastatin—atherosclerosis	0.000565	0.00179	CcSEcCtD
Doxazosin—Tinnitus—Niacin—atherosclerosis	0.000564	0.00178	CcSEcCtD
Doxazosin—Dysgeusia—Simvastatin—atherosclerosis	0.000562	0.00178	CcSEcCtD
Doxazosin—Flushing—Niacin—atherosclerosis	0.000562	0.00178	CcSEcCtD
Doxazosin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000558	0.00177	CcSEcCtD
Doxazosin—Tinnitus—Pravastatin—atherosclerosis	0.000556	0.00176	CcSEcCtD
Doxazosin—Malaise—Lovastatin—atherosclerosis	0.000553	0.00175	CcSEcCtD
Doxazosin—Flushing—Pravastatin—atherosclerosis	0.000553	0.00175	CcSEcCtD
Doxazosin—Muscle spasms—Simvastatin—atherosclerosis	0.000552	0.00174	CcSEcCtD
Doxazosin—Vertigo—Lovastatin—atherosclerosis	0.000551	0.00174	CcSEcCtD
Doxazosin—Leukopenia—Lovastatin—atherosclerosis	0.000549	0.00174	CcSEcCtD
Doxazosin—Chills—Niacin—atherosclerosis	0.000543	0.00172	CcSEcCtD
Doxazosin—Malaise—Ezetimibe—atherosclerosis	0.000543	0.00172	CcSEcCtD
Doxazosin—Vision blurred—Simvastatin—atherosclerosis	0.000541	0.00171	CcSEcCtD
Doxazosin—Arrhythmia—Niacin—atherosclerosis	0.000541	0.00171	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000538	0.0017	CcSEcCtD
Doxazosin—Tremor—Simvastatin—atherosclerosis	0.000538	0.0017	CcSEcCtD
Doxazosin—Alopecia—Niacin—atherosclerosis	0.000535	0.00169	CcSEcCtD
Doxazosin—Chills—Pravastatin—atherosclerosis	0.000535	0.00169	CcSEcCtD
Doxazosin—Insomnia—Rosuvastatin—atherosclerosis	0.000534	0.00169	CcSEcCtD
Doxazosin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000532	0.00168	CcSEcCtD
Doxazosin—Arrhythmia—Pravastatin—atherosclerosis	0.000532	0.00168	CcSEcCtD
Doxazosin—Palpitations—Ezetimibe—atherosclerosis	0.000532	0.00168	CcSEcCtD
Doxazosin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000531	0.00168	CcSEcCtD
Doxazosin—Malnutrition—Niacin—atherosclerosis	0.000527	0.00167	CcSEcCtD
Doxazosin—Alopecia—Pravastatin—atherosclerosis	0.000527	0.00167	CcSEcCtD
Doxazosin—Cough—Ezetimibe—atherosclerosis	0.000525	0.00166	CcSEcCtD
Doxazosin—Chest pain—Lovastatin—atherosclerosis	0.000522	0.00165	CcSEcCtD
Doxazosin—Myalgia—Lovastatin—atherosclerosis	0.000522	0.00165	CcSEcCtD
Doxazosin—Arthralgia—Lovastatin—atherosclerosis	0.000522	0.00165	CcSEcCtD
Doxazosin—Anxiety—Lovastatin—atherosclerosis	0.00052	0.00165	CcSEcCtD
Doxazosin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00052	0.00164	CcSEcCtD
Doxazosin—Hypertension—Ezetimibe—atherosclerosis	0.00052	0.00164	CcSEcCtD
Doxazosin—Flatulence—Niacin—atherosclerosis	0.000519	0.00164	CcSEcCtD
Doxazosin—Malaise—Simvastatin—atherosclerosis	0.000517	0.00164	CcSEcCtD
Doxazosin—Tension—Niacin—atherosclerosis	0.000517	0.00163	CcSEcCtD
Doxazosin—Discomfort—Lovastatin—atherosclerosis	0.000516	0.00163	CcSEcCtD
Doxazosin—Vertigo—Simvastatin—atherosclerosis	0.000516	0.00163	CcSEcCtD
Doxazosin—Leukopenia—Simvastatin—atherosclerosis	0.000514	0.00162	CcSEcCtD
Doxazosin—Myalgia—Ezetimibe—atherosclerosis	0.000512	0.00162	CcSEcCtD
Doxazosin—Chest pain—Ezetimibe—atherosclerosis	0.000512	0.00162	CcSEcCtD
Doxazosin—Arthralgia—Ezetimibe—atherosclerosis	0.000512	0.00162	CcSEcCtD
Doxazosin—Nervousness—Niacin—atherosclerosis	0.000512	0.00162	CcSEcCtD
Doxazosin—Flatulence—Pravastatin—atherosclerosis	0.000511	0.00162	CcSEcCtD
Doxazosin—Dry mouth—Lovastatin—atherosclerosis	0.000511	0.00162	CcSEcCtD
Doxazosin—Tension—Pravastatin—atherosclerosis	0.000509	0.00161	CcSEcCtD
Doxazosin—Dysgeusia—Pravastatin—atherosclerosis	0.000508	0.00161	CcSEcCtD
Doxazosin—Muscle spasms—Niacin—atherosclerosis	0.000507	0.0016	CcSEcCtD
Doxazosin—Discomfort—Ezetimibe—atherosclerosis	0.000506	0.0016	CcSEcCtD
Doxazosin—Pain—Rosuvastatin—atherosclerosis	0.000505	0.0016	CcSEcCtD
Doxazosin—Constipation—Rosuvastatin—atherosclerosis	0.000505	0.0016	CcSEcCtD
Doxazosin—Confusional state—Lovastatin—atherosclerosis	0.000505	0.0016	CcSEcCtD
Doxazosin—Nervousness—Pravastatin—atherosclerosis	0.000504	0.00159	CcSEcCtD
Doxazosin—Dry mouth—Ezetimibe—atherosclerosis	0.000501	0.00158	CcSEcCtD
Doxazosin—Muscle spasms—Pravastatin—atherosclerosis	0.000499	0.00158	CcSEcCtD
Doxazosin—Infection—Lovastatin—atherosclerosis	0.000497	0.00157	CcSEcCtD
Doxazosin—Vision blurred—Niacin—atherosclerosis	0.000497	0.00157	CcSEcCtD
Doxazosin—Confusional state—Ezetimibe—atherosclerosis	0.000495	0.00157	CcSEcCtD
Doxazosin—Thrombocytopenia—Lovastatin—atherosclerosis	0.00049	0.00155	CcSEcCtD
Doxazosin—Vision blurred—Pravastatin—atherosclerosis	0.000489	0.00155	CcSEcCtD
Doxazosin—Arthralgia—Simvastatin—atherosclerosis	0.000489	0.00154	CcSEcCtD
Doxazosin—Chest pain—Simvastatin—atherosclerosis	0.000489	0.00154	CcSEcCtD
Doxazosin—Myalgia—Simvastatin—atherosclerosis	0.000489	0.00154	CcSEcCtD
Doxazosin—Infection—Ezetimibe—atherosclerosis	0.000488	0.00154	CcSEcCtD
Doxazosin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000487	0.00154	CcSEcCtD
Doxazosin—Anxiety—Simvastatin—atherosclerosis	0.000487	0.00154	CcSEcCtD
Doxazosin—Tremor—Pravastatin—atherosclerosis	0.000486	0.00154	CcSEcCtD
Doxazosin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000483	0.00153	CcSEcCtD
Doxazosin—Discomfort—Simvastatin—atherosclerosis	0.000483	0.00153	CcSEcCtD
Doxazosin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000481	0.00152	CcSEcCtD
Doxazosin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000481	0.00152	CcSEcCtD
Doxazosin—Anorexia—Lovastatin—atherosclerosis	0.000477	0.00151	CcSEcCtD
Doxazosin—Skin disorder—Ezetimibe—atherosclerosis	0.000477	0.00151	CcSEcCtD
Doxazosin—Vertigo—Niacin—atherosclerosis	0.000473	0.0015	CcSEcCtD
Doxazosin—Syncope—Niacin—atherosclerosis	0.000473	0.00149	CcSEcCtD
Doxazosin—Confusional state—Simvastatin—atherosclerosis	0.000472	0.00149	CcSEcCtD
Doxazosin—Leukopenia—Niacin—atherosclerosis	0.000472	0.00149	CcSEcCtD
Doxazosin—Urticaria—Rosuvastatin—atherosclerosis	0.000469	0.00148	CcSEcCtD
Doxazosin—Oedema—Simvastatin—atherosclerosis	0.000468	0.00148	CcSEcCtD
Doxazosin—Malaise—Pravastatin—atherosclerosis	0.000468	0.00148	CcSEcCtD
Doxazosin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000467	0.00148	CcSEcCtD
Doxazosin—Vertigo—Pravastatin—atherosclerosis	0.000466	0.00147	CcSEcCtD
Doxazosin—Palpitations—Niacin—atherosclerosis	0.000466	0.00147	CcSEcCtD
Doxazosin—Infection—Simvastatin—atherosclerosis	0.000465	0.00147	CcSEcCtD
Doxazosin—Leukopenia—Pravastatin—atherosclerosis	0.000464	0.00147	CcSEcCtD
Doxazosin—Loss of consciousness—Niacin—atherosclerosis	0.000463	0.00146	CcSEcCtD
Doxazosin—Cough—Niacin—atherosclerosis	0.00046	0.00145	CcSEcCtD
Doxazosin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000459	0.00145	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000456	0.00144	CcSEcCtD
Doxazosin—Insomnia—Lovastatin—atherosclerosis	0.000453	0.00143	CcSEcCtD
Doxazosin—Cough—Pravastatin—atherosclerosis	0.000453	0.00143	CcSEcCtD
Doxazosin—Paraesthesia—Lovastatin—atherosclerosis	0.00045	0.00142	CcSEcCtD
Doxazosin—Arthralgia—Niacin—atherosclerosis	0.000449	0.00142	CcSEcCtD
Doxazosin—Myalgia—Niacin—atherosclerosis	0.000449	0.00142	CcSEcCtD
Doxazosin—Hypertension—Pravastatin—atherosclerosis	0.000448	0.00142	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000447	0.00141	CcSEcCtD
Doxazosin—Anorexia—Simvastatin—atherosclerosis	0.000446	0.00141	CcSEcCtD
Doxazosin—Dyspnoea—Lovastatin—atherosclerosis	0.000446	0.00141	CcSEcCtD
Doxazosin—Insomnia—Ezetimibe—atherosclerosis	0.000444	0.0014	CcSEcCtD
Doxazosin—Arthralgia—Pravastatin—atherosclerosis	0.000442	0.0014	CcSEcCtD
Doxazosin—Myalgia—Pravastatin—atherosclerosis	0.000442	0.0014	CcSEcCtD
Doxazosin—Chest pain—Pravastatin—atherosclerosis	0.000442	0.0014	CcSEcCtD
Doxazosin—Paraesthesia—Ezetimibe—atherosclerosis	0.000441	0.00139	CcSEcCtD
Doxazosin—Dyspepsia—Lovastatin—atherosclerosis	0.000441	0.00139	CcSEcCtD
Doxazosin—Anxiety—Pravastatin—atherosclerosis	0.00044	0.00139	CcSEcCtD
Doxazosin—Dry mouth—Niacin—atherosclerosis	0.000439	0.00139	CcSEcCtD
Doxazosin—Dyspnoea—Ezetimibe—atherosclerosis	0.000438	0.00138	CcSEcCtD
Doxazosin—Discomfort—Pravastatin—atherosclerosis	0.000436	0.00138	CcSEcCtD
Doxazosin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000435	0.00138	CcSEcCtD
Doxazosin—Decreased appetite—Lovastatin—atherosclerosis	0.000435	0.00138	CcSEcCtD
Doxazosin—Dyspepsia—Ezetimibe—atherosclerosis	0.000432	0.00137	CcSEcCtD
Doxazosin—Fatigue—Lovastatin—atherosclerosis	0.000432	0.00136	CcSEcCtD
Doxazosin—Oedema—Niacin—atherosclerosis	0.00043	0.00136	CcSEcCtD
Doxazosin—Pain—Lovastatin—atherosclerosis	0.000428	0.00135	CcSEcCtD
Doxazosin—Constipation—Lovastatin—atherosclerosis	0.000428	0.00135	CcSEcCtD
Doxazosin—Confusional state—Pravastatin—atherosclerosis	0.000427	0.00135	CcSEcCtD
Doxazosin—Decreased appetite—Ezetimibe—atherosclerosis	0.000427	0.00135	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000427	0.00135	CcSEcCtD
Doxazosin—Asthenia—Rosuvastatin—atherosclerosis	0.000424	0.00134	CcSEcCtD
Doxazosin—Insomnia—Simvastatin—atherosclerosis	0.000424	0.00134	CcSEcCtD
Doxazosin—Oedema—Pravastatin—atherosclerosis	0.000423	0.00134	CcSEcCtD
Doxazosin—Fatigue—Ezetimibe—atherosclerosis	0.000423	0.00134	CcSEcCtD
Doxazosin—Shock—Niacin—atherosclerosis	0.000423	0.00134	CcSEcCtD
Doxazosin—Infection—Pravastatin—atherosclerosis	0.000421	0.00133	CcSEcCtD
Doxazosin—Paraesthesia—Simvastatin—atherosclerosis	0.000421	0.00133	CcSEcCtD
Doxazosin—Pain—Ezetimibe—atherosclerosis	0.00042	0.00133	CcSEcCtD
Doxazosin—Constipation—Ezetimibe—atherosclerosis	0.00042	0.00133	CcSEcCtD
Doxazosin—Tachycardia—Niacin—atherosclerosis	0.00042	0.00133	CcSEcCtD
Doxazosin—Pruritus—Rosuvastatin—atherosclerosis	0.000418	0.00132	CcSEcCtD
Doxazosin—Skin disorder—Niacin—atherosclerosis	0.000418	0.00132	CcSEcCtD
Doxazosin—Dyspnoea—Simvastatin—atherosclerosis	0.000418	0.00132	CcSEcCtD
Doxazosin—Hyperhidrosis—Niacin—atherosclerosis	0.000416	0.00131	CcSEcCtD
Doxazosin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000415	0.00131	CcSEcCtD
Doxazosin—Feeling abnormal—Lovastatin—atherosclerosis	0.000413	0.0013	CcSEcCtD
Doxazosin—Dyspepsia—Simvastatin—atherosclerosis	0.000412	0.0013	CcSEcCtD
Doxazosin—Anorexia—Niacin—atherosclerosis	0.00041	0.0013	CcSEcCtD
Doxazosin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000409	0.00129	CcSEcCtD
Doxazosin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000409	0.00129	CcSEcCtD
Doxazosin—Decreased appetite—Simvastatin—atherosclerosis	0.000407	0.00129	CcSEcCtD
Doxazosin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000405	0.00128	CcSEcCtD
Doxazosin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000404	0.00128	CcSEcCtD
Doxazosin—Fatigue—Simvastatin—atherosclerosis	0.000404	0.00128	CcSEcCtD
Doxazosin—Anorexia—Pravastatin—atherosclerosis	0.000404	0.00128	CcSEcCtD
Doxazosin—Hypotension—Niacin—atherosclerosis	0.000402	0.00127	CcSEcCtD
Doxazosin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000402	0.00127	CcSEcCtD
Doxazosin—Pain—Simvastatin—atherosclerosis	0.0004	0.00127	CcSEcCtD
Doxazosin—Constipation—Simvastatin—atherosclerosis	0.0004	0.00127	CcSEcCtD
Doxazosin—Urticaria—Lovastatin—atherosclerosis	0.000398	0.00126	CcSEcCtD
Doxazosin—Body temperature increased—Lovastatin—atherosclerosis	0.000396	0.00125	CcSEcCtD
Doxazosin—Abdominal pain—Lovastatin—atherosclerosis	0.000396	0.00125	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000392	0.00124	CcSEcCtD
Doxazosin—Dizziness—Rosuvastatin—atherosclerosis	0.000391	0.00124	CcSEcCtD
Doxazosin—Urticaria—Ezetimibe—atherosclerosis	0.00039	0.00123	CcSEcCtD
Doxazosin—Insomnia—Niacin—atherosclerosis	0.000389	0.00123	CcSEcCtD
Doxazosin—Abdominal pain—Ezetimibe—atherosclerosis	0.000388	0.00123	CcSEcCtD
Doxazosin—Body temperature increased—Ezetimibe—atherosclerosis	0.000388	0.00123	CcSEcCtD
Doxazosin—Paraesthesia—Niacin—atherosclerosis	0.000386	0.00122	CcSEcCtD
Doxazosin—Feeling abnormal—Simvastatin—atherosclerosis	0.000386	0.00122	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000386	0.00122	CcSEcCtD
Doxazosin—Dyspnoea—Niacin—atherosclerosis	0.000383	0.00121	CcSEcCtD
Doxazosin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000383	0.00121	CcSEcCtD
Doxazosin—Insomnia—Pravastatin—atherosclerosis	0.000383	0.00121	CcSEcCtD
Doxazosin—Somnolence—Niacin—atherosclerosis	0.000382	0.00121	CcSEcCtD
Doxazosin—Paraesthesia—Pravastatin—atherosclerosis	0.00038	0.0012	CcSEcCtD
Doxazosin—Dyspepsia—Niacin—atherosclerosis	0.000379	0.0012	CcSEcCtD
Doxazosin—Dyspnoea—Pravastatin—atherosclerosis	0.000377	0.00119	CcSEcCtD
Doxazosin—Decreased appetite—Niacin—atherosclerosis	0.000374	0.00118	CcSEcCtD
Doxazosin—Dyspepsia—Pravastatin—atherosclerosis	0.000373	0.00118	CcSEcCtD
Doxazosin—Rash—Rosuvastatin—atherosclerosis	0.000373	0.00118	CcSEcCtD
Doxazosin—Dermatitis—Rosuvastatin—atherosclerosis	0.000372	0.00118	CcSEcCtD
Doxazosin—Urticaria—Simvastatin—atherosclerosis	0.000372	0.00118	CcSEcCtD
Doxazosin—Body temperature increased—Simvastatin—atherosclerosis	0.00037	0.00117	CcSEcCtD
Doxazosin—Abdominal pain—Simvastatin—atherosclerosis	0.00037	0.00117	CcSEcCtD
Doxazosin—Headache—Rosuvastatin—atherosclerosis	0.00037	0.00117	CcSEcCtD
Doxazosin—Hypersensitivity—Lovastatin—atherosclerosis	0.000369	0.00117	CcSEcCtD
Doxazosin—Decreased appetite—Pravastatin—atherosclerosis	0.000368	0.00116	CcSEcCtD
Doxazosin—Pain—Niacin—atherosclerosis	0.000368	0.00116	CcSEcCtD
Doxazosin—Fatigue—Pravastatin—atherosclerosis	0.000365	0.00115	CcSEcCtD
Doxazosin—Pain—Pravastatin—atherosclerosis	0.000362	0.00114	CcSEcCtD
Doxazosin—Constipation—Pravastatin—atherosclerosis	0.000362	0.00114	CcSEcCtD
Doxazosin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000362	0.00114	CcSEcCtD
Doxazosin—Asthenia—Lovastatin—atherosclerosis	0.000359	0.00114	CcSEcCtD
Doxazosin—Pruritus—Lovastatin—atherosclerosis	0.000354	0.00112	CcSEcCtD
Doxazosin—Asthenia—Ezetimibe—atherosclerosis	0.000352	0.00111	CcSEcCtD
Doxazosin—Gastrointestinal pain—Niacin—atherosclerosis	0.000352	0.00111	CcSEcCtD
Doxazosin—Nausea—Rosuvastatin—atherosclerosis	0.000351	0.00111	CcSEcCtD
Doxazosin—Feeling abnormal—Pravastatin—atherosclerosis	0.000349	0.0011	CcSEcCtD
Doxazosin—Pruritus—Ezetimibe—atherosclerosis	0.000347	0.0011	CcSEcCtD
Doxazosin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000346	0.00109	CcSEcCtD
Doxazosin—Hypersensitivity—Simvastatin—atherosclerosis	0.000345	0.00109	CcSEcCtD
Doxazosin—Diarrhoea—Lovastatin—atherosclerosis	0.000343	0.00108	CcSEcCtD
Doxazosin—Urticaria—Niacin—atherosclerosis	0.000342	0.00108	CcSEcCtD
Doxazosin—Body temperature increased—Niacin—atherosclerosis	0.00034	0.00107	CcSEcCtD
Doxazosin—Abdominal pain—Niacin—atherosclerosis	0.00034	0.00107	CcSEcCtD
Doxazosin—Urticaria—Pravastatin—atherosclerosis	0.000336	0.00106	CcSEcCtD
Doxazosin—Asthenia—Simvastatin—atherosclerosis	0.000336	0.00106	CcSEcCtD
Doxazosin—Diarrhoea—Ezetimibe—atherosclerosis	0.000336	0.00106	CcSEcCtD
Doxazosin—Body temperature increased—Pravastatin—atherosclerosis	0.000335	0.00106	CcSEcCtD
Doxazosin—Abdominal pain—Pravastatin—atherosclerosis	0.000335	0.00106	CcSEcCtD
Doxazosin—Pruritus—Simvastatin—atherosclerosis	0.000331	0.00105	CcSEcCtD
Doxazosin—Dizziness—Lovastatin—atherosclerosis	0.000331	0.00105	CcSEcCtD
Doxazosin—Dizziness—Ezetimibe—atherosclerosis	0.000325	0.00103	CcSEcCtD
Doxazosin—Diarrhoea—Simvastatin—atherosclerosis	0.00032	0.00101	CcSEcCtD
Doxazosin—Vomiting—Lovastatin—atherosclerosis	0.000318	0.00101	CcSEcCtD
Doxazosin—Hypersensitivity—Niacin—atherosclerosis	0.000317	0.001	CcSEcCtD
Doxazosin—Rash—Lovastatin—atherosclerosis	0.000316	0.000998	CcSEcCtD
Doxazosin—Dermatitis—Lovastatin—atherosclerosis	0.000315	0.000997	CcSEcCtD
Doxazosin—Headache—Lovastatin—atherosclerosis	0.000314	0.000992	CcSEcCtD
Doxazosin—Vomiting—Ezetimibe—atherosclerosis	0.000312	0.000987	CcSEcCtD
Doxazosin—Hypersensitivity—Pravastatin—atherosclerosis	0.000312	0.000986	CcSEcCtD
Doxazosin—Dizziness—Simvastatin—atherosclerosis	0.00031	0.000979	CcSEcCtD
Doxazosin—Rash—Ezetimibe—atherosclerosis	0.00031	0.000979	CcSEcCtD
Doxazosin—Dermatitis—Ezetimibe—atherosclerosis	0.000309	0.000978	CcSEcCtD
Doxazosin—Asthenia—Niacin—atherosclerosis	0.000309	0.000976	CcSEcCtD
Doxazosin—Headache—Ezetimibe—atherosclerosis	0.000308	0.000973	CcSEcCtD
Doxazosin—Pruritus—Niacin—atherosclerosis	0.000304	0.000962	CcSEcCtD
Doxazosin—Asthenia—Pravastatin—atherosclerosis	0.000304	0.000961	CcSEcCtD
Doxazosin—Pruritus—Pravastatin—atherosclerosis	0.0003	0.000947	CcSEcCtD
Doxazosin—Vomiting—Simvastatin—atherosclerosis	0.000298	0.000942	CcSEcCtD
Doxazosin—Nausea—Lovastatin—atherosclerosis	0.000297	0.00094	CcSEcCtD
Doxazosin—Rash—Simvastatin—atherosclerosis	0.000295	0.000934	CcSEcCtD
Doxazosin—Dermatitis—Simvastatin—atherosclerosis	0.000295	0.000933	CcSEcCtD
Doxazosin—Diarrhoea—Niacin—atherosclerosis	0.000294	0.00093	CcSEcCtD
Doxazosin—Headache—Simvastatin—atherosclerosis	0.000293	0.000928	CcSEcCtD
Doxazosin—Nausea—Ezetimibe—atherosclerosis	0.000292	0.000922	CcSEcCtD
Doxazosin—Diarrhoea—Pravastatin—atherosclerosis	0.00029	0.000916	CcSEcCtD
Doxazosin—Dizziness—Niacin—atherosclerosis	0.000284	0.000899	CcSEcCtD
Doxazosin—Dizziness—Pravastatin—atherosclerosis	0.00028	0.000885	CcSEcCtD
Doxazosin—Nausea—Simvastatin—atherosclerosis	0.000278	0.00088	CcSEcCtD
Doxazosin—Vomiting—Niacin—atherosclerosis	0.000273	0.000865	CcSEcCtD
Doxazosin—Rash—Niacin—atherosclerosis	0.000271	0.000857	CcSEcCtD
Doxazosin—Dermatitis—Niacin—atherosclerosis	0.000271	0.000857	CcSEcCtD
Doxazosin—Headache—Niacin—atherosclerosis	0.000269	0.000852	CcSEcCtD
Doxazosin—Vomiting—Pravastatin—atherosclerosis	0.000269	0.000851	CcSEcCtD
Doxazosin—Rash—Pravastatin—atherosclerosis	0.000267	0.000844	CcSEcCtD
Doxazosin—Dermatitis—Pravastatin—atherosclerosis	0.000267	0.000843	CcSEcCtD
Doxazosin—Headache—Pravastatin—atherosclerosis	0.000265	0.000839	CcSEcCtD
Doxazosin—Nausea—Niacin—atherosclerosis	0.000255	0.000808	CcSEcCtD
Doxazosin—Nausea—Pravastatin—atherosclerosis	0.000251	0.000795	CcSEcCtD
Doxazosin—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	1.57e-05	0.000191	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	1.56e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—HMOX1—atherosclerosis	1.56e-05	0.00019	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CETP—atherosclerosis	1.56e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	1.56e-05	0.00019	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.53e-05	0.000187	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.53e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	1.53e-05	0.000186	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.53e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	1.53e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	1.53e-05	0.000186	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LIPC—atherosclerosis	1.52e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLG—atherosclerosis	1.52e-05	0.000185	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOC3—atherosclerosis	1.51e-05	0.000184	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOB—atherosclerosis	1.51e-05	0.000184	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—MAPK3—atherosclerosis	1.51e-05	0.000183	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LDLR—atherosclerosis	1.51e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	1.5e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOB—atherosclerosis	1.49e-05	0.000182	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SCARB1—atherosclerosis	1.49e-05	0.000182	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.49e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AGT—atherosclerosis	1.49e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	1.49e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	1.48e-05	0.00018	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CETP—atherosclerosis	1.47e-05	0.000179	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB1—atherosclerosis	1.46e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—atherosclerosis	1.46e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—LEP—atherosclerosis	1.46e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	1.46e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTM1—atherosclerosis	1.45e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	1.45e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	1.45e-05	0.000176	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LPL—atherosclerosis	1.45e-05	0.000176	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.45e-05	0.000176	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	1.44e-05	0.000176	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	1.44e-05	0.000175	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—LPL—atherosclerosis	1.43e-05	0.000174	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	1.42e-05	0.000173	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLG—atherosclerosis	1.41e-05	0.000172	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMGCR—atherosclerosis	1.41e-05	0.000172	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.41e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	1.41e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	1.39e-05	0.00017	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GPX1—atherosclerosis	1.39e-05	0.000169	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	1.39e-05	0.000169	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	1.39e-05	0.000169	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.38e-05	0.000168	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—F2—atherosclerosis	1.38e-05	0.000168	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	1.37e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	1.36e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CD36—atherosclerosis	1.36e-05	0.000165	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOB—atherosclerosis	1.35e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	1.34e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	1.33e-05	0.000162	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.33e-05	0.000162	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	1.32e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	1.32e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	1.31e-05	0.00016	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.3e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	1.29e-05	0.000157	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.29e-05	0.000157	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	1.29e-05	0.000157	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTHFR—atherosclerosis	1.28e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LPL—atherosclerosis	1.28e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	1.27e-05	0.000154	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	1.26e-05	0.000154	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARA—atherosclerosis	1.26e-05	0.000153	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ABCA1—atherosclerosis	1.26e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOB—atherosclerosis	1.25e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	1.25e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—INS—atherosclerosis	1.25e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	1.24e-05	0.000151	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGT—atherosclerosis	1.24e-05	0.000151	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	1.23e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	1.23e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AGT—atherosclerosis	1.22e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	1.22e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	1.22e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LEP—atherosclerosis	1.21e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—atherosclerosis	1.21e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	1.21e-05	0.000147	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	1.21e-05	0.000147	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	1.2e-05	0.000146	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	1.2e-05	0.000146	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—atherosclerosis	1.2e-05	0.000146	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LPL—atherosclerosis	1.19e-05	0.000145	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CAV1—atherosclerosis	1.19e-05	0.000144	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.19e-05	0.000144	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOA1—atherosclerosis	1.18e-05	0.000144	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	1.16e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	1.16e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	1.15e-05	0.000139	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—F2—atherosclerosis	1.14e-05	0.000139	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	1.13e-05	0.000138	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	1.13e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	1.13e-05	0.000137	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.11e-05	0.000135	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—atherosclerosis	1.1e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—atherosclerosis	1.08e-05	0.000131	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—atherosclerosis	1.08e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—atherosclerosis	1.08e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—atherosclerosis	1.08e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	1.07e-05	0.00013	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	1.06e-05	0.00013	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOB—atherosclerosis	1.06e-05	0.000129	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	1.05e-05	0.000128	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	1.05e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—atherosclerosis	1.04e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—INS—atherosclerosis	1.04e-05	0.000126	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOB—atherosclerosis	1.03e-05	0.000126	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.000125	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	1.03e-05	0.000125	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—INS—atherosclerosis	1.02e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—atherosclerosis	1.02e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	1.02e-05	0.000124	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.02e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—atherosclerosis	1.02e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—F2—atherosclerosis	1.02e-05	0.000124	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LPL—atherosclerosis	1.01e-05	0.000123	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	1e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—atherosclerosis	1e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—atherosclerosis	1e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	9.91e-06	0.000121	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	9.89e-06	0.00012	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LPL—atherosclerosis	9.87e-06	0.00012	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—atherosclerosis	9.86e-06	0.00012	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOB—atherosclerosis	9.74e-06	0.000119	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	9.72e-06	0.000118	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	9.7e-06	0.000118	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—atherosclerosis	9.63e-06	0.000117	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD36—atherosclerosis	9.61e-06	0.000117	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	9.55e-06	0.000116	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	9.51e-06	0.000116	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.47e-06	0.000115	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—F2—atherosclerosis	9.43e-06	0.000115	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD36—atherosclerosis	9.38e-06	0.000114	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	9.37e-06	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—atherosclerosis	9.37e-06	0.000114	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	9.31e-06	0.000113	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LPL—atherosclerosis	9.3e-06	0.000113	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	9.23e-06	0.000112	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—INS—atherosclerosis	9.2e-06	0.000112	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.1e-06	0.000111	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	9.08e-06	0.000111	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—atherosclerosis	9.07e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	9.05e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	9.03e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—atherosclerosis	8.96e-06	0.000109	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARA—atherosclerosis	8.93e-06	0.000109	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	8.9e-06	0.000108	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—atherosclerosis	8.89e-06	0.000108	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD36—atherosclerosis	8.84e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	8.78e-06	0.000107	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARA—atherosclerosis	8.72e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	8.68e-06	0.000106	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—atherosclerosis	8.65e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	8.65e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—INS—atherosclerosis	8.55e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	8.54e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	8.51e-06	0.000104	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—atherosclerosis	8.48e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	8.45e-06	0.000103	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—atherosclerosis	8.44e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	8.41e-06	0.000102	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAV1—atherosclerosis	8.4e-06	0.000102	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOA1—atherosclerosis	8.38e-06	0.000102	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.37e-06	0.000102	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—atherosclerosis	8.27e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	8.27e-06	0.000101	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARA—atherosclerosis	8.21e-06	0.0001	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—atherosclerosis	8.2e-06	9.98e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAV1—atherosclerosis	8.2e-06	9.98e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOA1—atherosclerosis	8.18e-06	9.95e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	8.07e-06	9.82e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	8.05e-06	9.8e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—atherosclerosis	7.96e-06	9.68e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	7.88e-06	9.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	7.85e-06	9.55e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	7.8e-06	9.5e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—atherosclerosis	7.8e-06	9.49e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	7.78e-06	9.47e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAV1—atherosclerosis	7.72e-06	9.4e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOA1—atherosclerosis	7.71e-06	9.38e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	7.66e-06	9.32e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.65e-06	9.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	7.49e-06	9.12e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.47e-06	9.09e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	7.46e-06	9.07e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—atherosclerosis	7.38e-06	8.98e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	7.29e-06	8.87e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—INS—atherosclerosis	7.24e-06	8.81e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	7.23e-06	8.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	7.21e-06	8.77e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—atherosclerosis	7.21e-06	8.77e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	7.15e-06	8.71e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	7.09e-06	8.62e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—INS—atherosclerosis	7.07e-06	8.6e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	7.07e-06	8.6e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.04e-06	8.56e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	6.91e-06	8.41e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.8e-06	8.28e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—atherosclerosis	6.79e-06	8.26e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—INS—atherosclerosis	6.66e-06	8.11e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	6.65e-06	8.09e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—atherosclerosis	6.64e-06	8.08e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	6.54e-06	7.96e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—atherosclerosis	6.48e-06	7.89e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	6.48e-06	7.88e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	6.47e-06	7.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	6.42e-06	7.82e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	6.4e-06	7.79e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—atherosclerosis	6.35e-06	7.73e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	6.32e-06	7.69e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	6.29e-06	7.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	6.28e-06	7.64e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—atherosclerosis	6.2e-06	7.54e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	6.19e-06	7.53e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—atherosclerosis	6.11e-06	7.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	6.01e-06	7.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	6e-06	7.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	5.95e-06	7.24e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	5.85e-06	7.12e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—atherosclerosis	5.84e-06	7.11e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	5.83e-06	7.1e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.81e-06	7.07e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.81e-06	7.07e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.75e-06	7e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—atherosclerosis	5.67e-06	6.9e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.5e-06	6.69e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—atherosclerosis	5.45e-06	6.63e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	5.4e-06	6.57e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	5.35e-06	6.51e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.34e-06	6.5e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	5.33e-06	6.49e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	5.11e-06	6.22e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	5.03e-06	6.12e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	4.96e-06	6.03e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—atherosclerosis	4.52e-06	5.51e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	4.17e-06	5.08e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—atherosclerosis	4.12e-06	5.01e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	4.02e-06	4.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—atherosclerosis	3.73e-06	4.54e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.71e-06	4.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.44e-06	4.19e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—atherosclerosis	2.92e-06	3.55e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—atherosclerosis	2.85e-06	3.47e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—atherosclerosis	2.68e-06	3.27e-05	CbGpPWpGaD
